Outcome | Total n included in analysis (unadjus-ted/adjusted) | n(%) HPV vaccinated with outcome (unadjusted/adjusted) | n(%) non-vaccinated with outcome (unadjusted/adjusted) | OR (unadjusted) for being HPV vaccinated (95Â % CI) | p-value (unadjusted) | OR (adjusted)afor being HPV vaccinated (95Â % CI) | p-value (adjusted) |
---|---|---|---|---|---|---|---|
Screening intention | |||||||
 Yes vs. no/do not know | 835/783 | 562 (87.1)/535 (87.0) | 119 (62.6)/105 (62.5) | 4.04 (2.78–5.87) | <0.0001 | 3.89 (2.50–6.06) | <0.0001 |
Perceived cervical cancer riskb | |||||||
 <11 per 1000 women | 910/856 | 5 (0.7)/5 (0.8) | 12 (5.4)/11 (5.5) | 0.13 (0.05–0.37) | 0.0001 | 0.11 (0.03–0.39) | 0.0005 |
 <101 per 1000 women | 910/856 | 103 (15.0)/98 (14.9) | 64 (28.6)/55 (27.5) | 0.44 (0.31–0.63) | <0.0001 | 0.51 (0.33–0.78) | 0.0019 |
 <501 per 1000 women | 910/856 | 523 (76.2)/500 (76.2) | 177 (79.0)/158 (79.0) | 0.85 (0.59–1.23) | 0.3917 | 0.71 (0.46–1.09) | 0.1207 |
Perceived HPV vaccine effect | |||||||
 <0 % | 904/851 | 43 (6.3)/43 (6.6) | 53 (24.3)/44 (22.6) | 0.21 (0.13–0.32) | <0.0001 | 0.31 (0.18–0.51) | <0.0001 |
 <60 % | 904/851 | 179 (24.8)/163 (24.9) | 109 (50.0)/96 (49.2) | 0.33 (0.24–0.45) | <0.0001 | 0.37 (0.25–0.53) | <0.0001 |
 <95 % | 904/851 | 569 (82.9)/542 (82.6) | 191 (87.6)/173 (88.7) | 0.69 (0.44–1.08) | 0.1024 | 0.67 (0.39–1.13) | 0.1347 |